Saturn V Capital Management

Saturn V Capital Management as of March 31, 2023

Portfolio Holdings for Saturn V Capital Management

Saturn V Capital Management holds 18 positions in its portfolio as reported in the March 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Cymabay Therapeutics Common 10.6 $14M 1.6M 8.72
Crinetics Pharmaceuticals In Common (CRNX) 8.9 $12M 741k 16.06
Chinook Therapeutics Common 8.8 $12M 507k 23.15
Horizon Therapeutics SHS 8.1 $11M 99k 109.14
Biogen Common (BIIB) 7.8 $10M 38k 278.03
Cytokinetics Common (CYTK) 7.4 $10M 283k 35.19
Biocryst Pharmaceuticals Common (BCRX) 7.2 $9.7M 1.2M 8.34
Morphic Holding Common (MORF) 6.9 $9.3M 247k 37.64
Kalvista Pharmaceuticals Common (KALV) 6.6 $8.8M 1.1M 7.86
Ascendis Pharma A/s - Sponsored ADR (ASND) 6.2 $8.3M 77k 107.22
Apellis Pharmaceuticals Common (APLS) 6.1 $8.1M 123k 65.96
Iteos Therapeutics Common (ITOS) 4.9 $6.5M 481k 13.61
Sage Therapeutics Common (SAGE) 4.5 $6.1M 145k 41.96
Amicus Therapeutics Common (FOLD) 2.1 $2.9M 258k 11.09
Arcutis Biotherapeutics Common (ARQT) 1.5 $2.0M 178k 11.00
2seventy Bio Common (TSVT) 1.3 $1.8M 172k 10.20
Astria Therapeutics Common (ATXS) 1.0 $1.3M 101k 13.30
Scilex Holding Common (SCLX) 0.1 $85k 10k 8.20